Current position:Home >Product >
Piperazine, 1-(3-cyclopentyl-1-oxopropyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
Piperazine, 1-(3-cyclopentyl-1-oxopropyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride(502654-81-1)
- Name: Piperazine, 1-(3-cyclopentyl-1-oxopropyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- Synonyms:
- Molecular Formula:C23H32N4O2.2ClH
- Molecular Weight:
- CAS Registry Number:502654-81-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.502654-81-1 Piperazine, 1-(3-cyclopentyl-1-oxopropyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]

Other Product
- 502654-60-6/1-Piperazinecarboxylic acid, 4-[[6-[[4-(1H-pyrazol-3-yl)phenoxy]methyl]-3-pyridinyl]methyl]-, ethyl ester
- 502654-62-8/Pyridine, 5-(1-piperidinylmethyl)-2-[[4-(1H-pyrazol-3-yl)phenoxy]methyl]-, dihydrochloride
- 502654-63-9/1H-Pyrazole, 5-(4-butoxyphenyl)-1-methyl-, monohydrochloride
- 502654-64-0/1H-Pyrazole, 3-(4-butoxyphenyl)-4-methyl-
- 502654-65-1/1H-Pyrazole, 3-(4-butoxyphenyl)-5-methyl-
- 502654-66-2/Ethanamine, N,N-dimethyl-2-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethoxy]-
- 502654-67-3/1-Piperazinecarboxylic acid, 4-[3-[4-(1H-pyrazol-3-yl)phenoxy]propyl]-, ethyl ester, dihydrochloride
- 502654-69-5/Piperazine, 1-[(dimethylamino)acetyl]-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, trihydrochloride
- 502654-70-8/4-Piperidinecarboxylic acid, 1-[[4-(1H-pyrazol-3-yl)phenoxy]acetyl]-
- 502654-71-9/1-Piperazinecarboxylic acid, 4-[2-[4-(4-methyl-1H-pyrazol-3-yl)phenoxy]ethyl]-, ethyl ester, dihydrochloride
- 502654-72-0/1-Piperazinecarboxylic acid, 4-[4-[4-(1H-pyrazol-3-yl)phenoxy]butyl]-, ethyl ester, dihydrochloride
- 502654-73-1/1-Piperazinecarboxylic acid, 4-[5-[4-(1H-pyrazol-3-yl)phenoxy]pentyl]-, ethyl ester, dihydrochloride
- 502654-74-2/1-Piperazinecarboxylic acid, 4-[6-[4-(1H-pyrazol-3-yl)phenoxy]hexyl]-, ethyl ester, dihydrochloride
- 502654-75-3/1-Piperazinecarboxamide, N-hexyl-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-76-4/Piperazine, 1-(methylsulfonyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-77-5/Piperazine, 1-(ethylsulfonyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-78-6/1-Piperazinecarboxamide, N-propyl-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-79-7/Piperazine, 1-[(1-acetyl-4-piperidinyl)carbonyl]-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]eth yl]-, dihydrochloride
- 502654-80-0/Piperazine, 1-(cyclohexylacetyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-81-1/Piperazine, 1-(3-cyclopentyl-1-oxopropyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-82-2/Piperazine, 1-[(1-methyl-4-piperidinyl)carbonyl]-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]eth yl]-, trihydrochloride
- 502654-83-3/Piperazine, 1-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-4-(4,4,4-trifluoro-1-oxobutyl)-
- 502654-84-4/Piperazine, 1-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-4-(4,4,4-trifluoro-1-oxobutyl)-, dihydrochloride
- 502654-85-5/Piperazine, 1-(methoxyacetyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-86-6/Piperazine, 1-[3-(diethylamino)-1-oxopropyl]-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]- , trihydrochloride
- 502654-87-7/Piperazine, 1-(2-methyl-1-oxopropyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-88-8/Piperazine, 1-(4-methyl-1-oxopentyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-89-9/Piperazine, 1-(cyclobutylcarbonyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride
- 502654-90-2/Piperazine, 1-[1-oxo-3-(1-piperidinyl)propyl]-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]- , trihydrochloride
- 502654-91-3/Piperazine, 1-(cyanoacetyl)-4-[2-[4-(1H-pyrazol-3-yl)phenoxy]ethyl]-, dihydrochloride